Related references
Note: Only part of the references are listed.Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Daniel N. Frank et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats
Annaig Lan et al.
BRITISH JOURNAL OF NUTRITION (2007)
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria
Benoit Foligne et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: A study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis
Nadia Vasquez et al.
INFLAMMATORY BOWEL DISEASES (2007)
Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis
H. Sokol et al.
GUT (2007)
Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis
Margarita Martinez-Medina et al.
INFLAMMATORY BOWEL DISEASES (2006)
Review article:: the role of bacteria in onset and perpetuation of inflammatory bowel disease
P. Seksik et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model
Catherine Daniel et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease:: a randomised, double blind, placebo controlled GETAID trial
P. Marteau et al.
GUT (2006)
Specificities of the fecal microbiota in inflammatory bowel disease
H Sokol et al.
INFLAMMATORY BOWEL DISEASES (2006)
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
C Manichanh et al.
GUT (2006)
Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria:: Technical and microbiological aspects
B Foligné et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Reduced Paneth cell α-defensins in ileal Crohn's disease
J Wehkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease
A Swidsinski et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis
D Rachmilewitz et al.
GASTROENTEROLOGY (2004)
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis
S Rakoff-Nahoum et al.
CELL (2004)
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA
D Kelly et al.
NATURE IMMUNOLOGY (2004)
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression
J Wehkamp et al.
GUT (2004)
NF-κB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917:: A novel effect of a probiotic bacterium
J Wehkamp et al.
INFECTION AND IMMUNITY (2004)
Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis
B Sheil et al.
GUT (2004)
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
EV Loftus
GASTROENTEROLOGY (2004)
Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces
J Dabard et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Phylogenetic relationships of butyrate-producing bacteria from the human gut
A Barcenilla et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
Butyrate inhibits inflammatory responses through NF kappa B inhibition: implications for Crohn's disease
JP Segain et al.
GUT (2000)
Share Paper
